“…One of the major obstacles to the discovery of new drugs is the lack of general knowledge about the metabolism of organisms, especially during infection. This is exactly the case for C. neoformans, for which many studies focus on the potential antigen (Oliveira et al, 2021;Becerra-Álvarez et al, 2022;Nelson et al, 2022) and its functions and pathogenesis mechanisms (Sabiiti and May., 2012;Buchanan., 1998;Rhome et al, 2011;Waterman et al, 2012;Price et al, 2011;Mota Fernandes and Del Poeta., 2020;Gray et al, 2012;Anderson et al, 2014;Huang et al, 2016), and very few studies are carried out on the organism's primary metabolism (Shea et al, 2006;Garcia-Santamarina et al, 2018;Berguson et al, 2022;Jezewski et al, 2022;Kinskovski and Staats, 2022;Ma et al, 2022). Even with genomic information, using genome-scale data to understand and interpret the function of genes in terms of the general biology of the pathogen remains challenging for systems-level understanding.…”